NCT04964128View on ClinicalTrials.gov

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

June 10, 2022

Study Completion Date

July 26, 2022

Conditions
Type 1 Diabetes
Interventions
DEVICE

MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing)

The AHCL system with Meal Gesture Dosing evaluated in this study includes a commercial/CE-Marked insulin pump with investigational software, and the Klue Health mobile app with investigational software (installed on Apple Watch) for meal gesture detection and micro dosing.

Trial Locations (1)

Unknown

Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT04964128 - Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter